Endometriosis Innovation: RISE Forum Advances Research & Care

The 2025 EndoRISE Fall Forum, hosted by The Jackson Laboratory (JAX), signals a critical turning point in the fight against endometriosis – a disease historically sidelined by research funding and societal stigma. While awareness is growing, the fact that it affects an estimated 200 million globally, yet remains poorly understood, underscores the urgency of initiatives like EndoRISE. This isn’t simply a medical issue; it’s a public health crisis impacting workforce participation, economic productivity, and the overall well-being of a significant portion of the population.

Endometriosis, characterized by the growth of uterine-like tissue outside the uterus, causes debilitating pain, infertility, and is the leading cause of hysterectomies in individuals of reproductive age. For decades, diagnosis has been delayed – averaging 7-10 years – due to a lack of awareness, dismissed symptoms, and a historical bias in medical research that underfunded conditions primarily affecting women. The establishment of EndoRISE by JAX and the University of Connecticut School of Medicine represents a proactive, multi-faceted approach, addressing the disease from biological research to policy advocacy. The forum itself is a direct result of Connecticut’s commitment to addressing this gap, spurred by legislative action and a growing demand for better care.

The presentations at the forum revealed a promising shift towards more granular understanding of the disease. Dr. Katie Burns’ work on menstrual blood diagnostics offers the potential for less invasive and earlier detection. The exploration of a link between Lyme disease and endometriosis, while preliminary, opens up entirely new avenues for investigation into potential environmental triggers and co-morbidities. Keynote speaker Stacey Missmer’s emphasis on genetic associations and the power of community reinforces the need for large-scale data collection and collaborative research efforts.

The Forward Look

The EndoRISE Fall Forum wasn’t just a conference; it was a launchpad. The next 12-18 months will be critical. Expect to see:

• Increased State-Level Legislation: Following the example of Connecticut, other states will likely introduce bills aimed at increasing endometriosis research funding, improving provider education, and ensuring insurance coverage for specialized care. State Representative Jillian Gilchrest’s involvement signals a growing political will to address the issue.
• Expansion of EndoRISE Model: The success of the JAX/UConn collaboration will likely serve as a blueprint for similar initiatives in other states, fostering regional hubs for endometriosis research and care.
• Focus on Biomarker Discovery: The research presented suggests a growing emphasis on identifying reliable biomarkers for early diagnosis and personalized treatment. This will likely attract further investment from both public and private sectors.
• Greater Patient Engagement in Research: The forum’s emphasis on patient voices will translate into more patient-centered research designs and a greater focus on addressing the holistic needs of individuals living with endometriosis.

Ultimately, the long-term impact of EndoRISE and events like this forum will be measured by tangible improvements in diagnosis, treatment, and quality of life for those affected by endometriosis. The momentum is building, but sustained commitment and continued collaboration will be essential to finally turn the tide against this debilitating disease.